NVIDIA Invests in Genesis Therapeutics to Advance AI-Powered Drug Development

Spread the love

Genesis Therapeutics, a private biotech company based in London and focused on artificial intelligence, has secured funding from NVentures, NVIDIA’s (NVDA, Financial) corporate venture capital arm. However, the company remains undisclosed on…

Article Source
https://finance.yahoo.com/news/nvidia-invests-genesis-therapeutics-advance-145824964.html